171P Pharmacodynamic (PD) biomarker analysis from CheckMate (CM) 8KX: A multitumor study of a subcutaneous (SC) formulation of nivolumab (NIVO) monotherapy by Jackson, C.G.C.A., Perumal, D., Lugowska, I., O’Donnell, A., North, R.T., Calvo Ferrandiz, P.A., Latten-Jansen, L.M., Sánchez, C.G., Medina Rodríguez, L.M., Santoro, A., Li, L., Sidik, K., Tang, T., Deutsch, J.S., Taube, J., Horak, C., Ravimohan, S., Lonardi, S.

Get full text